Cell adhesion molecule poliovirus receptor (PVR, CD155, Necl5, or Tage4) is an appealing target with immunomodulatory functions (7), since it has been shown to mediate oncologic immunity by interacting with receptors on T and natural killer (NK) cells to regulate the function of tumor infiltrating lymphocytes (8). The gene discussed is PVR; the disease is neoplasm.